维普期刊资源整合服务平台（V6.5）

84篇 您的检索式：作者名="LAMPERTICO M"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics 显示文摘	Lampertico P Maher J S Gerber M A	1991	Hepatology1991，13，3：	1
2	Long -term outcome of hepatitis B in lamivudine-resistant cirrhotic patients显示文摘	Lampertico P Vigano M Romeo R	2002	J Hepatol2002，，：	1
3	Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistance hepatitis B patients显示文摘	Lampertico P Vigano M Manenti E	2007	Gastroenterology2007，133，5：	1
4	Long-term outcome of hepatitis B in lamivudine-resistant cirrhotic patients显示文摘	LAMPERTICO P VIGANO M ROMEO R	2002	J Hepatol2002，36，1：	1
5	Low resistance to adefovir combined with lamivudine 3-year study of 145 lamivudine-resistant hepatitis B patients显示文摘	Lampertico P Vigano M Manenti E et a!	2007	Gastroenterology2007，133，：	1
6	Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine显示文摘	Lampertico P Vigano M Manenti E	2005	Hepatology2005，42，：	1
7	Response-guided peginterferon alfa-2a therapy based on HBsAg levels at week 12 and week 24 or 48 improves respose rates in HBeAg negative genotype D patients显示文摘	Lampertico P Vigano M Di Costanzo GC		0，，2：	1
8	Pharmaco-kinetic studies of silybin-phosphatidylcholine complex ( IdB 1016) in liver cirrhosis after multiple doses显示文摘	ORLANDO R FRAGASSO A LAMPERTICO M	1991	Med Sci Res1991，19，23：	1
9	Low Resistance to Adefovir Combined with Lamivudine: a 3-year Study of 145 Lamivudine-resistant Hepatitis B Patients显示文摘	Lampertico P Vigano M Manenti E	2007	Gastroenterology2007，133，：	1
10	Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B By 24-month interferon therapy显示文摘	Lampertico P Del Ninno E Viganò M		Hepatology0，，：	1
11	IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroelearance in genotype D hepatitis B e mltigen- negative patients with chronic hepatitis B 显示文摘	Lampertico P Viganb M Cheroni C	2013	Hepatol2013，57，3：	1
12	Low resistance to adefovir combined lamivudine:a 3-year study of 145 lamivudine- resistant hepatitis B patients显示文摘	Lampertico P Vigano M Manenti E	2007	Gastroenterology2007，133，5：	1
13	Riske of hepatitis B surface antigen seroreversion after allogenic hematopoitic SCT显示文摘	VIGANO M VENER C LAMPERTICO P	2011	Bone Marrow Trans plant2011，46，：	1
14	Tenofovir (TDF) for chronic hepatitis B patients with suboptimal response to adefovir (ADV) or ADV/LAM treatment:results of the optibitallan multicenter prospective open label study显示文摘	Levrero M Cimino L Lampertico P		Hepatology0，，：	1
15	Randomised study comparing 48 and 96 weeks peginterferon alpha-2a therapy in genotype D HBeAg-negative chronic hepatitis B显示文摘	Lampertico P Vigano M Di Costanzo GG et aI	2013	Gut2013，62，2：	1
16	Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B显示文摘	Vigan6 M Valenti L Lampertico P	2013	Hepatology2013，58，4：	1
17	Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine显示文摘	Lampertico P Viganò M Manenti E	2005	Hepatology2005，42，6：	1
18	HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years 显示文摘	Fasano M Lampertico P Marzano A	2012	J Hepatol2012，56，6：	1
19	High prevalence of reduced bone mineral density in patients with chronic hepatitis B under nucleos(t)ides analogues treatment显示文摘	Vigano M Lampertico P Eller-Vainicher C et a/	2010	AASLD2010，414，：	1
20	Development and application of an in vitro model for screening anti hepatitis B virus therapeutics 显示文摘	Lampertico P Malter J S Gerber M A	1991	Hepatology1991，13，3：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示